Active surveillance for low-risk prostate cancer in African American Men: A multi-institutional experience

Urology

Volumn 83, Issue 2, 2014, Pages 364-368

  Odom, Brian D ^a   Mir, M C ^b   Hughes, Scott ^a   Senechal, Cedric ^c   Santy, Alexis ^c   Eyraud, Remi ^c   Stephenson, Andrew J ^b   Ylitalo, Kelly ^d   Miocinovic, Ranko ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICANS; AGED; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WATCHFUL WAITING;

EID: 84895067191     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.09.038     Document Type: Article

References (30)

1. G. Draisma, R. Boer, and S.J. Otto et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer J Natl Cancer Inst 95 2003 868 878
2. R. Etzioni, D.F. Penson, and J.M. Legler et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends J Natl Cancer Inst 94 2002 981 990
3. L. Klotz, L. Zhang, and A. Lam et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
4. R.C. Van Den Bergh, S. Roemeling, and M.J. Roobol et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly Eur Urol 55 2009 1 8
5. M. Bul, X. Zhu, and R. Valdagni et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study Eur Urol 63 2013 597 603
6. E.D. Selvadurai, M. Singhera, and K. Thomas et al. Medium-term outcomes of active surveillance for localised prostate cancer Eur Urol 2013
7. L. Klotz Active surveillance for prostate cancer: patient selection and management Curr Oncol 17 Suppl 2 2010 S11 S17
8. S.P. Elliott, M.V. Meng, and E.P. Elkin et al. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE J Urol 178 2007 529 534 discussion 534
9. Y. Pardo, F. Guedea, and F. Aguilo et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687 4696
10. L.R. Schover, R.T. Fouladi, and C.L. Warneke et al. Defining sexual outcomes after treatment for localized prostate carcinoma Cancer 95 2002 1773 1785
11. H.K. Tsai, A.V. D'amico, and N. Sadetsky et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality J Natl Cancer Inst 99 2007 1516 1524
12. H.B. Carter, A. Kettermann, and C. Warlick et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience J Urol 178 2007 2359 2364 discussion 2364-5
13. A. Khatami, G. Aus, and J.E. Damber et al. PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section Int J Cancer 120 2007 170 174
14. S. Roemeling, M.J. Roobol, and S.H. De Vries et al. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome Eur Urol 51 2007 1244 1250 discussion 1251
15. M.S. Soloway, C.T. Soloway, and S. Williams et al. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience BJU Int 101 2008 165 169
16. N.J. Van As, and C.C. Parker Active surveillance with selective radical treatment for localized prostate cancer Cancer J 13 2007 289 294
17. T.J. Wilt, M.K. Brawer, and K.M. Jones et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
18. R.K. Berglund, T.A. Masterson, and K.C. Vora et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964 1967 discussion 1967-8
19. S.E. Eggener, A. Mueller, and R.K. Berglund et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer J Urol 181 2009 1635 1641 discussion 1641
20. R. Miocinovic, J.S. Jones, and A.C. Pujara et al. Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria Urology 77 2011 980 984
21. M.R. Abern, M.R. Bassett, and M. Tsivian et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 85 90
22. Y.S. Ha, A. Salmasi, and M. Karellas et al. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance Urology 81 2013 831 835
23. V. Iremashvili, M.S. Soloway, and D.L. Rosenberg et al. Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance J Urol 187 2012 1594 1599
24. I.J. Powell, C.H. Bock, and J.J. Ruterbusch et al. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity J Urol 183 2010 1792 1796
25. I.J. Powell, J. Dey, and A. Dudley et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis Urology 59 2002 907 912
26. C.R. Ritch, B.F. Morrison, and G. Hruby et al. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison BJU Int 111 2013 E186 E190
27. K. Schwartz, I.J. Powell, and W. Underwood 3rd et al. Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer Urology 74 2009 1296 1302
28. K.A. Moses, A.T. Paciorek, and D.F. Penson et al. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE J Clin Oncol 28 2010 1069 1074
29. M. Bul, X. Zhu, and A. Rannikko et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study Eur Urol 62 2012 195 200
30. A.S. Duffield, T.K. Lee, and H. Miyamoto et al. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2278